USFDA issues 3 observations for Granules India Gagillapur facility Ruchika Sharma16 Jan 2023 9:00 AM GMTHyderabad: Granules India has recently announced that US Food and Drug Administration (USFDA) has concluded Pre-Approval Inspection (PAI) with three...
Granules Pharma US facility gets 6 observations from USFDA Ruchika Sharma23 July 2022 10:27 AM GMTNew Delhi: Drug firm Granules India today announced that the US Food and Drug Administration (USFDA) has issued six observations after the...
Granules India arm gets 3 USFDA observations for Chantilly facility Ruchika Sharma31 Jan 2022 7:32 AM GMTHyderabad: Granules India Limited announced that Granules Pharmaceuticals, Inc. (GPI), a wholly-owned foreign subsidiary of the company, located in...
Granules India secures USFDA nod for Potassium Chloride for Oral Solution Ruchika Sharma28 Jan 2022 10:46 AM GMTHyderabad: Granules India Limited announced today that the US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug...
KVS Ram Rao appointed Granules India Joint MD, CEO Medical Dialogues Bureau5 Jan 2022 4:00 AM GMTRao has previously worked at various companies like Dr Reddys Laboratories, Jubilant Life Sciences and Gujarat Heavy Chemicals.
Emcure, Glenmark arm, 3 others line up Rs 7000 crore IPOs Ruchika Sharma28 May 2021 7:30 AM GMTMumbai: Amidst the raging second wave of the COVID-19 pandemic and many fearing a third wave, the healthcare sector is in the limelight for the...
Granules India to provide 16 crore free Paracetamol tablets to Telangana Ruchika Sharma13 May 2021 6:59 AM GMTHyderabad: Granules India, a city-based vertically integrated pharmaceutical company, has announced that it pledged to provide the Telangana...
Granules India board clears proposal to set up subsidiary in Hyderabad Ruchika Sharma10 Nov 2020 6:09 AM GMTNew Delhi: Drug firm Granules India on Monday said its board has approved a proposal to set up a subsidiary in Hyderabad to build a greenfield...
Granules India Dexmethylphenidate HCl ER capsules get USFDA approval to treat ADHD Ruchika Sharma13 Sep 2020 4:30 AM GMTHyderabad: Drugmaker Granules India has recently announced that the company's US subsidiary has received marketing approval from the U.S. Health...
Granules India clarifies on recall of 4.78 lakh bottles of Metformin Hydrochloride ER tablets in US Ruchika Sharma28 July 2020 9:44 AM GMTHyderabad: Over the past weekend, there were several media sources that claimed that Granules India recalls 4.78 lakh bottles of diabetes drugs-...
Lupin, Granules India recall diabetes drug Metformin Hydrochloride ER tablets in US Ruchika Sharma27 July 2020 6:10 AM GMTAs per the USFDA, the companies are recalling the product due to deviation from the current good manufacturing practices (CGMP).
Granules India net profit up 34 percent to Rs 111.4 crore in Q1 Ruchika Sharma19 July 2020 4:15 AM GMT"This is the result of operational excellence and a vigilant watch over our margins through optimization of the product mix and by increased...
